From gestational hypertension and preeclampsia to atypical hemolytic uremic syndrome

Obstetrics and Gynecology

Volumn 127, Issue 5, 2016, Pages 907-910

  Tsai, Han Mou ^a,b   Kuo, Elizabeth ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b IMAH Hematology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; CREATININE; ECULIZUMAB; HAPTOGLOBIN; HEMOGLOBIN; LABETALOL; LACTATE DEHYDROGENASE; NIFEDIPINE;

ADULT; ANASARCA; ARTICLE; ASCITES; CASE REPORT; CLINICAL ARTICLE; CONFUSION; DIAGNOSTIC ERROR; DISEASE CONTROL; FEMALE; GENE MUTATION; GESTATIONAL AGE; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MATERNAL HYPERTENSION; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA EXCHANGE; PLATELET COUNT; PLEURA EFFUSION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; SCOTOMA; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; YOUNG ADULT; COMPLICATION; DECISION TREE; DIFFERENTIAL DIAGNOSIS; HEMOLYTIC-UREMIC SYNDROME; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS;

DECISION TREES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HELLP SYNDROME; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS; YOUNG ADULT;

EID: 84964057239     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001340     Document Type: Article

References (8)

1. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007;18:2281-4.
2. Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 2013;8:554-62.
3. Tsai HM. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome. Transfus Med Rev 2014;28:187-97.
4. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005.
5. Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLos Med 2011;8:e1001013.
6. Tsai HM, Kuo E. Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome. Adv Hematol 2014;2014:295323.
7. Tsai HM. Does anticomplement therapy have a role in the management of malignant hypertension? J Clin Hypertens (Greenwich) 2015. doi: 10.1111/jch.12664 [Epub ahead of print].
8. Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005;17:239-45.